Parts matching “CMV promoter” · all types
Viral immediate-early enhancer/promoter from human cytomegalovirus that drives strong, constitutive transcription across most transfected mammalian cell types. One of the most widely used promoters for transient transfection, recombinant protein production, and reporter constructs. Subject to progressive transcriptional silencing in some tissues in vivo.
Immediate-early enhancer/promoter from simian cytomegalovirus (SCMV), built around a palindromic-repeat enhancer upstream of the viral IE94 gene that drives strong basal transcription without needing a tissue-restricted activator (Chang et al. 1990). A higher-output alternative to the human CMV promoter for constitutive transgene expression in mammalian cells and transgenic zebrafish.
Human cytomegalovirus immediate-early enhancer/promoter followed by a chimeric intron (β-globin splice donor, immunoglobulin heavy-chain branch point and splice acceptor) placed upstream of the transgene. The intron is spliced out of the mature mRNA and increases expression over an intron-less CMV cassette, the design used in vectors such as pCI-neo.
Synthetic hybrid promoter combining the CMV immediate-early enhancer, the chicken β-actin promoter, and an SV40 intron; drives strong, ubiquitous constitutive expression in mammalian cells. Compact ~800 bp variant used in AAV and other gene-therapy vectors, distinct from the larger CAG promoter, which substitutes a rabbit β-globin intron for the SV40 intron.
Compact hybrid promoter combining the CMV immediate-early enhancer with the chicken β-actin promoter, engineered by replacing the CBA promoter's SV40 intron with a chimeric chicken β-actin/MVM intron. Drives strong, ubiquitous constitutive expression, including in spinal and brainstem motor neurons where the parental CBA promoter performs poorly.
Distal promoter of the Drosophila melanogaster cytoskeletal actin 5C (Act5C) gene, one of two alternative promoters that transcribe the gene from separate start sites (Bond and Davidson 1986). Drives strong constitutive expression, comparable to the induced Mtn promoter, in stably transfected Drosophila S2 cells (Angelichio et al. 1991).
Synthetic hybrid promoter combining the CMV immediate-early enhancer, the chicken β-actin promoter, and a rabbit β-globin splice acceptor/intron, engineered for very high constitutive expression across mammalian cell types and tissues. One of the strongest promoters available for transgenic animals, viral vectors, and stable cell lines.
5' regulatory region of the mouse Cnp gene (2',3'-cyclic nucleotide 3'-phosphodiesterase) that directs expression to oligodendrocytes in the CNS and Schwann cells in the PNS, tracking the developmental onset of endogenous Cnp expression during myelination (Gravel et al. 1998; Yuan et al. 2002). Standard promoter for targeting reporters to the oligodendrocyte lineage.
Truncated core fragment of the human cytomegalovirus immediate-early promoter (~56 bp, retaining the TATA box but lacking the major upstream enhancer), giving near-zero basal transcription alone. Used as a neutral minimal-promoter scaffold that is efficiently activated when paired with an upstream enhancer or tissue-specific regulatory element, including in dual-cassette AAV constructs.
Compact 1.3 kb fragment of the mouse Camk2a gene promoter that restricts AAV and lentiviral transgene expression predominantly to excitatory pyramidal neurons in cortex and hippocampus. Widely used to drive optogenetic and chemogenetic constructs in forebrain circuits; also produces detectable expression in a subset of cortical GABAergic interneurons.
Truncated cauliflower mosaic virus 35S promoter spanning roughly the -343 to +8 region relative to the transcription start site, containing the full enhancer and core elements but omitting additional far-upstream sequence present in longer CaMV35S constructs. Retains essentially the full-length promoter's constitutive transcriptional strength in dicot plant tissues.
Mouse Hb9 (Mnx1) enhancer element fused to a 68-bp cytomegalovirus (CMV) minimal promoter, used in lentiviral vectors to drive transgene expression selectively in spinal cord motor neurons. Developed for gene delivery to motor neurons in models of amyotrophic lateral sclerosis (ALS) and other motor neuron diseases.
Early promoter/enhancer region from simian virus 40 (SV40), constitutively active across a broad range of mammalian cell types. Weaker than the strongest viral and hybrid promoters but compact and reliable, commonly used to drive selection-marker genes (e.g., neomycin, puromycin resistance) in expression vectors so that a separate, stronger promoter can drive the gene of interest.
Synthetic RNA polymerase II core promoter combining the TATA box, initiator (Inr), motif ten element (MTE), and downstream promoter element (DPE) in a single cassette. Directs markedly higher basal transcription than the natural cytomegalovirus IE1 and adenovirus major late core promoters, and is used as a compact, high-activity core-promoter scaffold in expression and reporter vectors.
Constitutive promoter from the human ubiquitin C gene; provides stable expression across most mammalian cell types, including tissues such as liver and brain where the CMV, H2-Kb, and Pgk-1 promoters commonly show restricted or low activity. Widely used in lentiviral, AAV, and transgenic constructs requiring broad tissue coverage.
Truncated ~418 bp (-375 to +43) chicken cardiac troponin T (cTnT) promoter fragment that restricts transgene expression almost exclusively to cardiomyocytes. Standard compact cardiac-specific promoter for systemic AAV delivery, giving strong myocardial expression with minimal expression in skeletal muscle or other tissues.
Housekeeping promoter cloned from the mouse Pgk1 gene, which encodes a glycolytic enzyme expressed in every cell. Drives constitutive, moderate-level expression across essentially all cell types and is a standard choice for selectable-marker and reporter cassettes in gene-targeting vectors and transgenic mice, in place of viral promoters.
Genomic promoter/intergenic region of the mouse alpha-myosin heavy chain (Myh6) gene, spanning roughly 5.5 kb between the Myh6 and Myh7 loci, that drives cardiomyocyte-restricted transgene expression in both ventricles and atria. Includes thyroid hormone-responsive elements and is developmentally upregulated after birth, mirroring the endogenous fetal-to-adult myosin isoform switch.
Retroviral LTR promoter engineered from a PCC4-cell-passaged myeloproliferative sarcoma virus (PCMV) enhancer combined with a dl-587rev-derived leader sequence, giving murine stem cell virus (MSCV) LTR activity in undifferentiated embryonic and hematopoietic cells that the parental PCMV/Moloney LTR lacks. A standard promoter for retroviral and lentiviral transgene delivery to stem and progenitor cells.
Synthetic 770 bp hybrid promoter combining a 190 bp murine alpha-myosin heavy chain (alphaMHC) enhancer with a 570 bp abbreviated muscle creatine kinase (MCK) regulatory cassette, giving high-level expression in both skeletal and cardiac muscle. The strongest characterized muscle-specific cassette for AAV-mediated micro-dystrophin delivery in Duchenne muscular dystrophy gene therapy, including the FDA-approved product Elevidys.
Modified myeloproliferative sarcoma virus (MPSV) U3 long terminal repeat promoter carrying a negative control region (NCR) deletion and a dl-587rev primer-binding-site substitution, giving strong, stable expression in hematopoietic and pluripotent cells that resists the silencing seen with standard Moloney murine leukemia virus LTRs. Widely used in lentiviral and gammaretroviral vectors for hematopoietic stem cell gene therapy.
Enhanced cauliflower mosaic virus 35S promoter (2×CaMV35S) containing a tandem duplication of the upstream enhancer domain fused to a single copy of the core promoter; drives constitutive transcription roughly 10-fold stronger than the standard single-enhancer CaMV35S promoter in transgenic plants. Used in Agrobacterium-mediated dicot transformation vectors when maximal constitutive expression is required.
Constitutive promoter from the human EEF1A1 gene (elongation factor 1 alpha), a housekeeping gene expressed in essentially all cell types. Drives strong, stable transgene expression that resists the silencing seen with viral promoters, making it a standard choice for lentiviral and AAV vectors intended for long-term expression in dividing and non-dividing human cells.
Retroviral LTR promoter derived from spleen focus-forming virus (SFFV) that drives strong constitutive transcription in hematopoietic stem cells, progenitors, and differentiated blood lineages. Used as an internal promoter in gammaretroviral and lentiviral vectors for hematopoietic gene transfer and gene therapy.